SFX by Ex Libris Inc.

Title:	Up-regulation of Na+ ,K+ -ATPase α3-isoform and down-regulation of the α1-isoform in human colorectal cancer
Source:	Febs Letters [0014-5793] Sakai, Hideki yr:2004

Basic

Full text

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wallace, D C C. "Mitochondrial mutations in cancer." Oncogene 25.34 (2006): 4647-62.
description	2.	Yang, P. "Cellular location and expression of Na , K -ATPase α subunits affect the anti-proliferative activity of oleandrin." Molecular carcinogenesis 53.4 (2013): 253-263.
description	3.	Yang, P. "Oleandrin-mediated inhibition of human tumor cell proliferation: Importance of Na,K-ATPase Î± subunits as drug targets." Molecular cancer therapeutics 8.8 (2009): 2319-2328.
description	4.	Pelicano, H. "Glycolysis inhibition for anticancer treatment." Oncogene 25.34 (2006): 4633-4646.
description	5.	Chatterjee, A. "Mitochondrial DNA mutations in human cancer." Oncogene 25.34 (2006): 4663-4674.
description	6.	"Neuroprotective effects of mitoquinone and oleandrin on Parkinson’s disease model in zebrafish." International journal of neuroscience. 130.6: 574-582.
description	7.	Jortani, S. "Inhibition of Na,K-ATPase by oleandrin and oleandrigenin, and their detection by digoxin immunoassays." Clinical Chemistry 42.10 (1996): 1654-1658.
description	8.	Paula, S. "Interactions between cardiac glycosides and sodium/potassium-ATPase: Three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition." Biochemistry 44.2 (2005): 498-510.
description	9.	Kalyanasundaram, A. "SERCA pump isoforms: their role in calcium transport and disease." Muscle & nerve 35.4 (2007): 430-42.
description	10.	Wallace, D C C. "Mitochondrial diseases in man and mouse." Science 283.5407: 1482-1488.
description	11.	Taniguchi, T. "Molecular pathogenesis of Fanconi anemia: recent progress." Blood 107.11 (2006): 4223-33.
description	12.	Leder, P. "Mitochondriotoxic compounds for cancer therapy." Oncogene 25.34 (2006): 4787-97.
description	13.	Chen, Z. "The Warburg effect and its cancer therapeutic implications." Journal of Bioenergetics and Biomembranes 39.3 (2007): 267-74.
description	14.	Galluzzi, L. "Mitochondria as therapeutic targets for cancer chemotherapy." Oncogene 25.34 (2006): 4812-4830.
description	15.	Feng, P. "Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia." Cancer research 65.2: 613-621.
description	16.	Kim, Jung-whan W. "Cancer's molecular sweet tooth and the Warburg effect." Cancer research 66.18 (2006): 8927-30.
description	17.	McKenzie, M. "Mitochondrial disease: mutations and mechanisms." Neurochemical Research 29.3 (2004): 589-600.
description	18.	Liu, W. "siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity." Digestive Diseases and Sciences 54.1 (2009): 89-96.
description	19.	Schwinger, Robert H G H. "Modulation of SERCA: implications for the failing human heart." Basic research in cardiology 97.1 (2002): 1-8.
description	20.	Tan, H. "A calcium sensor in the sodium channel modulates cardiac excitability." Nature 415.6870 (2002): 442-447.